Relevance of Network Hierarchy in Cancer Drug-Target Selection

Aritro Nath, Christina Chan

    Research output: Chapter in Book/Report/Conference proceedingChapter

    • 1 Citations

    Abstract

    Targeted therapies aim to prevent cancer progression by inactivating tumor-specific signaling pathways. However, identifying a suitable drug target in the signaling network remains a major hurdle. Since signaling pathways can be considered as directional networks with hierarchical topology, we hypothesized that the hierarchical level of a candidate in the network impacts its efficiency as a drug-Target. This hypothesis was evaluated with three methods. First, Boolean modeling was applied to a hierarchical regulatory network to assess the impact of hierarchy on modulating the network output. Next, we analyzed the hierarchy of FDA-Approved drugs mapped onto pathways involved in prostate cancer. Finally, we converted a global transcriptional regulatory and signaling network into hierarchical networks to analyze the hierarchical distribution of cancer genes and the approved drug-Targets for cancer treatment.

    Original languageEnglish (US)
    Title of host publicationSystems Biology in Cancer Research and Drug Discovery
    PublisherSpringer Netherlands
    Pages339-362
    Number of pages24
    ISBN (Print)9789400748194, 9400748183, 9789400748187
    DOIs
    StatePublished - Aug 1 2013

    Profile

    Neoplasms
    Neoplasm Genes
    Prostatic Neoplasms

    Keywords

    • Boolean modeling
    • Hierarchical network
    • Prostate cancer
    • Targeted therapy

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Nath, A., & Chan, C. (2013). Relevance of Network Hierarchy in Cancer Drug-Target Selection. In Systems Biology in Cancer Research and Drug Discovery (pp. 339-362). Springer Netherlands. DOI: 10.1007/978-94-007-4819-4_15

    Relevance of Network Hierarchy in Cancer Drug-Target Selection. / Nath, Aritro; Chan, Christina.

    Systems Biology in Cancer Research and Drug Discovery. Springer Netherlands, 2013. p. 339-362.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Nath, A & Chan, C 2013, Relevance of Network Hierarchy in Cancer Drug-Target Selection. in Systems Biology in Cancer Research and Drug Discovery. Springer Netherlands, pp. 339-362. DOI: 10.1007/978-94-007-4819-4_15
    Nath A, Chan C. Relevance of Network Hierarchy in Cancer Drug-Target Selection. In Systems Biology in Cancer Research and Drug Discovery. Springer Netherlands. 2013. p. 339-362. Available from, DOI: 10.1007/978-94-007-4819-4_15

    Nath, Aritro; Chan, Christina / Relevance of Network Hierarchy in Cancer Drug-Target Selection.

    Systems Biology in Cancer Research and Drug Discovery. Springer Netherlands, 2013. p. 339-362.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    @inbook{fe14da784d584e3b93ec3f6a8299b7c2,
    title = "Relevance of Network Hierarchy in Cancer Drug-Target Selection",
    abstract = "Targeted therapies aim to prevent cancer progression by inactivating tumor-specific signaling pathways. However, identifying a suitable drug target in the signaling network remains a major hurdle. Since signaling pathways can be considered as directional networks with hierarchical topology, we hypothesized that the hierarchical level of a candidate in the network impacts its efficiency as a drug-Target. This hypothesis was evaluated with three methods. First, Boolean modeling was applied to a hierarchical regulatory network to assess the impact of hierarchy on modulating the network output. Next, we analyzed the hierarchy of FDA-Approved drugs mapped onto pathways involved in prostate cancer. Finally, we converted a global transcriptional regulatory and signaling network into hierarchical networks to analyze the hierarchical distribution of cancer genes and the approved drug-Targets for cancer treatment.",
    keywords = "Boolean modeling, Hierarchical network, Prostate cancer, Targeted therapy",
    author = "Aritro Nath and Christina Chan",
    year = "2013",
    month = "8",
    doi = "10.1007/978-94-007-4819-4_15",
    isbn = "9789400748194",
    pages = "339--362",
    booktitle = "Systems Biology in Cancer Research and Drug Discovery",
    publisher = "Springer Netherlands",

    }

    TY - CHAP

    T1 - Relevance of Network Hierarchy in Cancer Drug-Target Selection

    AU - Nath,Aritro

    AU - Chan,Christina

    PY - 2013/8/1

    Y1 - 2013/8/1

    N2 - Targeted therapies aim to prevent cancer progression by inactivating tumor-specific signaling pathways. However, identifying a suitable drug target in the signaling network remains a major hurdle. Since signaling pathways can be considered as directional networks with hierarchical topology, we hypothesized that the hierarchical level of a candidate in the network impacts its efficiency as a drug-Target. This hypothesis was evaluated with three methods. First, Boolean modeling was applied to a hierarchical regulatory network to assess the impact of hierarchy on modulating the network output. Next, we analyzed the hierarchy of FDA-Approved drugs mapped onto pathways involved in prostate cancer. Finally, we converted a global transcriptional regulatory and signaling network into hierarchical networks to analyze the hierarchical distribution of cancer genes and the approved drug-Targets for cancer treatment.

    AB - Targeted therapies aim to prevent cancer progression by inactivating tumor-specific signaling pathways. However, identifying a suitable drug target in the signaling network remains a major hurdle. Since signaling pathways can be considered as directional networks with hierarchical topology, we hypothesized that the hierarchical level of a candidate in the network impacts its efficiency as a drug-Target. This hypothesis was evaluated with three methods. First, Boolean modeling was applied to a hierarchical regulatory network to assess the impact of hierarchy on modulating the network output. Next, we analyzed the hierarchy of FDA-Approved drugs mapped onto pathways involved in prostate cancer. Finally, we converted a global transcriptional regulatory and signaling network into hierarchical networks to analyze the hierarchical distribution of cancer genes and the approved drug-Targets for cancer treatment.

    KW - Boolean modeling

    KW - Hierarchical network

    KW - Prostate cancer

    KW - Targeted therapy

    UR - http://www.scopus.com/inward/record.url?scp=84933533032&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84933533032&partnerID=8YFLogxK

    U2 - 10.1007/978-94-007-4819-4_15

    DO - 10.1007/978-94-007-4819-4_15

    M3 - Chapter

    SN - 9789400748194

    SN - 9400748183

    SN - 9789400748187

    SP - 339

    EP - 362

    BT - Systems Biology in Cancer Research and Drug Discovery

    PB - Springer Netherlands

    ER -